Justin N. Siemian, PhD

2013-2017 State University of New York, Buffalo, Buffalo, NY, United States 
 2018- NIH/NIDA, Rockville, MD, United States 
"Justin Siemian"
Mean distance: 19 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Siemian JN, Arenivar MA, Sarsfield S, et al. (2021) An excitatory lateral hypothalamic circuit orchestrating pain behaviors in mice. Elife. 10
Laing BT, Siemian JN, Sarsfield S, et al. (2020) Fluorescence microendoscopy for in vivo deep-brain imaging of neuronal circuits. Journal of Neuroscience Methods. 109015
Siemian JN, Sarsfield S, Aponte Y. (2020) Glutamatergic fast-spiking parvalbumin neurons in the lateral hypothalamus: Electrophysiological properties to behavior. Physiology & Behavior. 221: 112912
Martin JA, Werner CT, Mitra S, et al. (2019) A novel role for the actin-binding protein drebrin in regulating opiate addiction. Nature Communications. 10: 4140
Siemian JN, Borja CB, Sarsfield S, et al. (2019) Lateral hypothalamic fast-spiking parvalbumin neurons modulate nociception through connections in the periaqueductal gray area. Scientific Reports. 9: 12026
Schiffino FL, Siemian JN, Petrella M, et al. (2019) Activation of a lateral hypothalamic-ventral tegmental circuit gates motivation. Plos One. 14: e0219522
Xue Z, Siemian JN, Zhu Q, et al. (2018) Further pharmacological comparison of D-methamphetamine and L-methamphetamine in rats: abuse-related behavioral and physiological indices. Behavioural Pharmacology
Siemian JN, Shang L, Seaman RW, et al. (2018) Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats. Behavioural Pharmacology
Kisner A, Slocomb JE, Sarsfield S, et al. (2018) Electrophysiological properties and projections of lateral hypothalamic parvalbumin positive neurons. Plos One. 13: e0198991
Witkin JM, Smith JL, Ping X, et al. (2018) Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA receptors: Improved bioavailability enhances anticonvulsant efficacy. Neuropharmacology. 137: 332-343
See more...